T Lymphoblastic Leukemia/Lymphoma — Trials

T Lymphoblastic Leukemia/Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

140 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 57
Recruiting: 35
Ph III recruiting: 2
Growth YoY: —
Industry share: 12%
Top sponsor: Institute of Hematology & Blood Diseases Hospital, China
Termination share: 48.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (24)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06633341	Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-lymphoma	recruiting	Early Phase 1	30	Zhejiang UniversityOTHER	1	Oct 9, 2024	clinicaltrials
NCT06633354	Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-ALL	recruiting	Early Phase 1	30	Zhejiang UniversityOTHER	1	Oct 9, 2024	clinicaltrials